7月,药明康德(603259.SH/2359.HK)发布业绩预增公告,2025年上半年预计实现营业收入约207.99亿元,同比增长约20.64%,其中来自持续经营业务收入同比增长24.24%;预计归母净利润约85.61亿元,同比增长约101.92%;扣非归母净利润约55.82亿元,同比增长26.44%。一个值得注意的细节是:本期非经常性损益项目对利润的影响主要来自出售持有的WuXi XDC ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.